E-Lambda LLC

Corvallis, OR · Medtech

Smart surface-enhanced Raman scattering (S-SERS) system for rapid detection of illicit drugs and metabolites in municipal wastewater using diatomaceous SERS substrates and machine-learning analysis al

Grants
$352K
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
1
0 granted · 1 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Rapid Assessment of Drug Abuse from Municipal Wastewater by Smart Surface-Enhanced Raman Scattering Technique$252,130
Federal grantDepartment of Agriculture · Development Of Portable Marine Toxin Biosensors For Shellfish Industry$100,000
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2066OPTOSURGICAL LLC——
2067ACETAMINOPHEN TOXICITY DIAGNOSTICS, LLC——
2068BIOPEPTIDES CORP——
2069E-Lambda LLC——
207021MedTech LLC——
2071VIZMA LIFE SCIENCES INC——
2072Double Helix Optics Inc——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 1
  • Dynamic Free-space Femto-cells For High Speed Optical Communicationapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.